Multimodality Imaging-Based Therapeutic Decision in Ischemic Cardiomyopathy and Ventricular Tachycardia – a Case Report

Abstract Introduction In patients with ischemic heart disease and coronary chronic total occlusion, it is extremely important to assess the presence of myocardial viability via different cardiac imaging techniques in order to predict a potential functional recovery following revascularization. Multimodality cardiac imaging techniques estimate the risk of sudden cardiac death and personalize patient selection for primary prevention implantable cardioverterdefibrillator therapy. Case presentation A 61-year-old patient with a history of an extensive anterior myocardial infarction with conservative management (8 years before the current presentation, when the coronary angiography revealed two-vessel chronic total occlusion) presented to our outpatient service for fast-paced palpitations at home and fatigue. At the time of the index hospitalization, the patient refused coronary artery bypass grafting. During this period, he did not undergo any cardiovascular evaluation, but he did follow the pharmacological recommendations from the initial hospital discharge. Given the detection of multiple premature ventricular contractions and numerous episodes of nonsustained ventricular tachycardia during this medical visit, a multimodal imaging evaluation was conducted, which further guided the implementation of a personalized therapy. Conclusions In patients with ischemic heart failure and coronary chronic total occlusion, presenting with ventricular tachycardia, the therapeutic decision should be based on the results of a multi-modality cardiac imaging evaluation.

[1]  W. Cubała,et al.  Commentary concerning treatment of depression in patients with heart failure according to 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2022, European journal of preventive cardiology.

[2]  aguda y crónica,et al.  Comments on the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2022, Revista espanola de cardiologia.

[3]  A. Editorial Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. , 2022, Revista espanola de cardiologia.

[4]  G. Sinagra,et al.  [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.

[5]  I. V. Van Gelder,et al.  2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2021, European heart journal.

[6]  J. Chan,et al.  Global longitudinal strain as a prognostic marker in cardiac resynchronisation therapy: A systematic review , 2021, International journal of cardiology. Heart & vasculature.

[7]  T. Akasaka,et al.  Global longitudinal strain evaluated by speckle‐tracking echocardiography as a surrogate marker for predicting replacement fibrosis detected by magnetic resonance‐late gadolinium enhancement in patients with nonischemic cardiomyopathy , 2021, Journal of clinical ultrasound : JCU.

[8]  ESC / EAS Guidelines for the Treatment of Dyslipidemias: Lipid Modification to Reduce Cardiovascular Risk , 2020, Digital Doctor.

[9]  Jeroen J. Bax,et al.  2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC) , 2020, Russian Journal of Cardiology.

[10]  G. Hindricks,et al.  2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. , 2019, Atherosclerosis.

[11]  M. Dweck,et al.  Myocardial fibrosis: why image, how to image and clinical implications , 2019, Heart.

[12]  V. Reddy,et al.  Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease: Indications, Strategies, and Outcomes-Part II. , 2017, Journal of the American College of Cardiology.

[13]  S. Saito,et al.  A unique complication of the retrograde approach in angioplasty for chronic total occlusion of the coronary artery , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[14]  James A. White,et al.  Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis. , 2017, JACC. Heart failure.